Genetic Diseases

Top Story

Healio to provide live coverage of The Liver Meeting 2017

October 21, 2017
Meeting News

Kanuma improves liver markers in patients with lysosomal acid lipase deficiency

December 6, 2016
BOSTON — Kanuma improved various liver markers, as well as reduced liver fibrosis and cirrhosis, in children and adults with lysosomal acid lipase deficiency…

Arrowhead discontinues multiple drug candidates for liver disease

December 1, 2016
Arrowhead Pharmaceuticals announced it has discontinued development of three drugs currently being investigated in clinical trials for the treatment of various forms of…
FDA News

FDA grants rare pediatric disease label to investigational drug for NPC

November 30, 2016
The FDA has issued rare pediatric disease designation to an investigational gene therapy product candidate for the treatment of children with Niemann-Pick Type C1…
More Headlines »
CME

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients…
More »
GI Bookshelf

Question 48: When Should A Pancreatic Duct Stent Be Used?

From Curbside Consultation of the Pancreas: 49 Clinical Questions
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: Pegylated FGF21 treatment improves metabolic markers in NASH

October 23, 2017
More »
Advertisement
Advertisement